ClinicalTrialsFinder

MuSK MG Clinical Trials in New Haven, Connecticut

1 recruitingNew Haven, Connecticut

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis

Myasthenia GravisGeneralized MyastheniaAChR Myasthenia Gravis+1 more
COUR Pharmaceutical Development Company, Inc.54 enrolled17 locationsNCT06106672